New cases tested for RR-/MDR-TB (%) in Austria
Austria: New cases tested for RR-/MDR-TB was 87.0% in 2024. ▼ Falling
New cases tested for RR-/MDR-TB in Austria, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Austria recorded 87.0% for new cases tested for rr-/mdr-tb in 2024.
Compared with earlier readings it is up 1.2% on the previous year and up 7.4% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in Austria peaked at 100.0% in 2005 and was at its lowest, 71.0%, in 2017.
That places Austria 111th out of 192 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently falling across the 19 years of available data.
New cases tested for RR-/MDR-TB in Austria, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 100.0% | — |
| 2006 | 100.0% | +0.0% |
| 2007 | 100.0% | +0.0% |
| 2009 | 100.0% | +0.0% |
| 2010 | 97.0% | -3.0% |
| 2011 | 95.0% | -2.1% |
| 2012 | 93.0% | -2.1% |
| 2013 | 100.0% | +7.5% |
| 2014 | 81.0% | -19.0% |
| 2015 | 90.0% | +11.1% |
| 2016 | 88.0% | -2.2% |
| 2017 | 71.0% | -19.3% |
| 2018 | 90.0% | +26.8% |
| 2019 | 87.0% | -3.3% |
| 2020 | 87.0% | +0.0% |
| 2021 | 87.0% | +0.0% |
| 2022 | 82.0% | -5.7% |
| 2023 | 86.0% | +4.9% |
| 2024 | 87.0% | +1.2% |
Austria compared with similar countries
- Austria's 87.0% is below the median for high income countries, which is 91.0%, 96% of the median. (64 countries reporting)
- Austria's 87.0% is below the median for Europe & Central Asia, which is 91.0%, 96% of the median. (49 countries reporting)
Biggest year-on-year movements
Years where New cases tested for RR-/MDR-TB in Austria changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2018 | +26.8% | 71.0% | 90.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 100.0% | 4 |
| 2010s | 89.2% | 71.0% | 100.0% | 10 |
| 2020s | 85.8% | 82.0% | 87.0% | 5 |
Countries ranked near Austria
More health data for Austria
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.05 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,266 deaths per 1,000 people (2090)
- Number of infants who die before age 1 27 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.92 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0217 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.86 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in Austria?
- New cases tested for rr-/mdr-tb in Austria was 87.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in Austria?
- The highest recorded value was 100.0% in 2005.
- What is the lowest new cases tested for rr-/mdr-tb recorded in Austria?
- The lowest recorded value was 71.0% in 2017.
- How does Austria rank for new cases tested for rr-/mdr-tb?
- Austria ranks 111th out of 192 countries with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in Austria?
- Over the last ten years it is up 7.4%. The long-run trend across the full record is falling.
- Where does this Austria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).